Donal Kaehler
Profile
Donal Kaehler is the founder of NeoClone Biotechnology International LLC, which was founded in 1999.
Former positions of Donal Kaehler
Companies | Position | End |
---|---|---|
NeoClone Biotechnology International LLC
NeoClone Biotechnology International LLC BiotechnologyHealth Technology NeoClone Biotechnology International LLC engages in the production and supply of monoclonal antibody products. The firm offers antibodies to bacterial transcription proteins, RNA polymerase II, bacterial toxins, eukaryotic transcription proteins, neural proteins, cancer proteins, cardiac biomarkers, and interferon gamma, as well as offers cancer antibodies and Softag products. It provides contract monoclonal antibodies for companies and individual researchers, as well as for university and industry researchers. The company was founded in 1999 by Mark Jackson, Donal Kaehler, David Largaspaeda and Deven McGlenn and is headquartered in Madison, WI. | Founder | - |
Experiences
Positions held
Linked companies
Private companies | 1 |
---|---|
NeoClone Biotechnology International LLC
NeoClone Biotechnology International LLC BiotechnologyHealth Technology NeoClone Biotechnology International LLC engages in the production and supply of monoclonal antibody products. The firm offers antibodies to bacterial transcription proteins, RNA polymerase II, bacterial toxins, eukaryotic transcription proteins, neural proteins, cancer proteins, cardiac biomarkers, and interferon gamma, as well as offers cancer antibodies and Softag products. It provides contract monoclonal antibodies for companies and individual researchers, as well as for university and industry researchers. The company was founded in 1999 by Mark Jackson, Donal Kaehler, David Largaspaeda and Deven McGlenn and is headquartered in Madison, WI. | Health Technology |
- Stock Market
- Insiders
- Donal Kaehler